| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DRNA | Dicerna Pharmaceuticals Inc | Doberstein Stephen K | Director | Dec 28, 2021 | Option Exercise | $38.25 | 3,333 | 127,487 | 0 | Dec 29, 2021, 04:19 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Sep 05, 2019 | Buy | $17.28 | 15,000 | 259,200 | 107,668 | Sep 09, 2019, 05:09 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Aug 16, 2019 | Sale | $18.15 | 3,245 | 58,897 | 92,668 | Aug 19, 2019, 07:06 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | May 16, 2019 | Sale | $31.37 | 3,461 | 108,572 | 95,913 | May 17, 2019, 08:18 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Feb 19, 2019 | Sale | $42.39 | 3,310 | 140,311 | 99,374 | Feb 21, 2019, 08:13 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Nov 16, 2018 | Sale | $38.25 | 4,524 | 173,043 | 78,734 | Nov 19, 2018, 06:11 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Aug 16, 2018 | Option Exercise | $58.40 | 6,701 | 391,338 | 83,258 | Aug 16, 2018, 09:43 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | May 16, 2018 | Sale | $83.39 | 3,435 | 286,445 | 63,959 | May 18, 2018, 07:01 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Apr 06, 2018 | Option Exercise | $50.39 | 221,000 | 11,137,250 | 177,894 | Apr 09, 2018, 08:21 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Apr 09, 2018 | Option Exercise | $51.67 | 99,000 | 5,115,330 | 116,894 | Apr 09, 2018, 08:21 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Feb 16, 2018 | Sale | $82.94 | 2,426 | 201,212 | 67,394 | Feb 20, 2018, 07:07 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Nov 16, 2017 | Option Exercise | $44.23 | 4,782 | 211,508 | 43,820 | Nov 17, 2017, 06:03 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Nov 06, 2017 | Option Exercise | $17.25 | 41,828 | 721,742 | 52,016 | Nov 08, 2017, 06:01 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Nov 07, 2017 | Option Exercise | $17.66 | 150,818 | 2,662,692 | 106,511 | Nov 08, 2017, 06:01 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Nov 08, 2017 | Option Exercise | $19.81 | 600,000 | 11,886,000 | 331,102 | Nov 08, 2017, 06:01 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Oct 05, 2017 | Option Exercise | $17.25 | 87,354 | 1,506,856 | 74,779 | Oct 10, 2017, 06:06 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Aug 16, 2017 | Sale | $19.32 | 1,701 | 32,863 | 31,102 | Aug 18, 2017, 07:01 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | May 16, 2017 | Sale | $19.55 | 1,701 | 33,255 | 32,803 | May 18, 2017, 08:45 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Apr 05, 2017 | Sale | $15.62 | 200,000 | 3,123,000 | 134,504 | Apr 07, 2017, 06:07 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Feb 16, 2017 | Sale | $13.14 | 1,261 | 16,570 | 34,504 | Feb 17, 2017, 08:02 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Nov 16, 2016 | Sale | $13.96 | 670 | 9,353 | 18,265 | Nov 18, 2016, 06:07 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Aug 16, 2016 | Sale | $17.56 | 1,336 | 23,460 | 18,935 | Aug 17, 2016, 05:37 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | May 16, 2016 | Option Exercise | $0.00010 | 875 | 0 | 1,360 | May 18, 2016, 05:15 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | May 17, 2016 | Sale | $13.58 | 339 | 4,604 | 1,021 | May 18, 2016, 05:15 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Feb 16, 2016 | Option Exercise | $0.00010 | 875 | 0 | 875 | Feb 18, 2016, 07:47 PM | |
| NKTR | NEKTAR THERAPEUTICS | Doberstein Stephen K | SVP & Chief Scientific Officer | Feb 17, 2016 | Sale | $11.92 | 390 | 4,649 | 485 | Feb 18, 2016, 07:47 PM |
Menu